Celltrion

068270 · KOSPI · Health Care · LARGE CAP

Updated terms.

Celltrion updated the disclosed terms of an acquisition of Celltrion USA, Inc., now worth US$515M.

M&A([Amended] Decision to acquire shares/equity in another company)· FILED 2026-05-11· RCEPT 20260511800665

US$515MDeal value
3.6%vs. company assets

Converted at 1 USD ≈ ₩1,474.45 (filing-date rate, 2026-05-11 close)

What happened

Celltrion updated the disclosed terms of an acquisition of Celltrion USA, Inc., now worth US$515M.

For context, this deal is worth about 3.6% of the company's own total assets.

TargetCelltrion USA, Inc.
Deal valueUS$515M
vs. company assets3.6%
Filed2026-05-11, [Amended] Decision to acquire shares/equity in another company
SourceDART rcept 20260511800665 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-11 (KST). · Converted at 1 USD ≈ ₩1,322 (rate of 2026-10-22).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.